F.D.A. Approves New Treatment for Early Alzheimer’s IT’S ALL IN YOUR HEAD – Jan. 6, 2023 - The approval of the drug, lecanemab, to be marketed as Leqembi, is likely to generate considerable interest from patients and physicians. Studies of the drug — an i... Read More...Big PharmaBooks, Memoirs, Films, and MediainterventionJan 10 2023Mental HealthRecovery